Characteristics of antigen-induced regulatory T cells
. | Means of regulatory T-cell induction . | . | . | . | . | . | . | . | . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Trs . | Mucosal M-DCs . | Cutaneous M-DCs . | PDCs . | IDCs . | Blocking antibodies* . | LFA-3 . | Notch-L . | IL10 . | ||||||||
Phenotype | CD8+ CD28- | CD4+ or CD8+ | CD4+ CD25- | CD8+ | CD4+ or CD8+ | CD4+ CD25+/- | CD4+ CD25+ | CD4+ or CD8+ | CD4+ (Tr1) | ||||||||
MHC restriction | Yes | No | No | No | No | No | No | No | No | ||||||||
Suppression mediator | |||||||||||||||||
Cytokines | No | Yes | No | Yes | Yes | Yes | Yes | No | Yes | ||||||||
T cell-T cell interaction | No | ? | Yes | No | Yes | ? | Yes | Yes | Yes | ||||||||
T cell-APC interaction | Yes | ? | Yes | No | Yes | ? | ? | Yes | ? | ||||||||
Antigen specificity | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||||||||
Reference number | 29 | 31, 32, 34 | 38 | 27 | 52-55 | 23, 26, 43 | 58 | 65-67 | 68 |
. | Means of regulatory T-cell induction . | . | . | . | . | . | . | . | . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Trs . | Mucosal M-DCs . | Cutaneous M-DCs . | PDCs . | IDCs . | Blocking antibodies* . | LFA-3 . | Notch-L . | IL10 . | ||||||||
Phenotype | CD8+ CD28- | CD4+ or CD8+ | CD4+ CD25- | CD8+ | CD4+ or CD8+ | CD4+ CD25+/- | CD4+ CD25+ | CD4+ or CD8+ | CD4+ (Tr1) | ||||||||
MHC restriction | Yes | No | No | No | No | No | No | No | No | ||||||||
Suppression mediator | |||||||||||||||||
Cytokines | No | Yes | No | Yes | Yes | Yes | Yes | No | Yes | ||||||||
T cell-T cell interaction | No | ? | Yes | No | Yes | ? | Yes | Yes | Yes | ||||||||
T cell-APC interaction | Yes | ? | Yes | No | Yes | ? | ? | Yes | ? | ||||||||
Antigen specificity | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||||||||
Reference number | 29 | 31, 32, 34 | 38 | 27 | 52-55 | 23, 26, 43 | 58 | 65-67 | 68 |
Ts indicates regulatory T cells induced by stimulating peripheral blood mononuclear cells (PBMCs) with irradiated allogeneic PBMCs depleted of CD2+ cells; M-DCs, mature myeloid dendritic cells; PDCs: plasmacytoid dendritic cells; iDCs, immature myeloid dendritic cells; LFA-3, leukocyte function- associated antigen 3; Notch-L, Notch ligand; IL10: interleukin 10; ?, unknown.
CD3, CD4, CD8, CD40 ligand mAbs.